Artificial Intelligence in Colonoscopy for Cancer Prevention
Removal precancerous polyps (so-called adenomas) during colonoscopy reduces colorectal cancer incidence and mortality. We have recently developed artificial intelligence (AI) systems which optimise colonoscopy quality by aiming at...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
ONCODIR
ONCODIR – Evidence-based Participatory Decision Making for C...
8M€
Cerrado
AMX DATA
Identification of risk factors for the development of colore...
130K€
Cerrado
PTQ2020-010990
VALIDACIÓN CLÍNICA Y ANALÍTICA DE UN TEST DE DETECCIÓN TEMPR...
38K€
Cerrado
ONCOSCREEN
A European shield against colorectal cancer based on novel,...
13M€
Cerrado
ONCOSCREEN
A European “shield” against colorectal cancer based on novel...
13M€
Cerrado
CPP2021-008536
Tecnologías para la detección temprana del cáncer colorrecta...
607K€
Cerrado
Información proyecto ACCEPT
Duración del proyecto: 30 meses
Fecha Inicio: 2021-03-09
Fecha Fin: 2023-09-23
Líder del proyecto
Innovasjon Norge
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
214K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Removal precancerous polyps (so-called adenomas) during colonoscopy reduces colorectal cancer incidence and mortality. We have recently developed artificial intelligence (AI) systems which optimise colonoscopy quality by aiming at increasing the detection of adenomas. However, it is unknown if this benefit of AI translates into improved cancer prevention.
To establish the role of AI in colorectal cancer prevention, we here propose a three-step research portfolio targeting individuals in the national colorectal cancer screening programmes in Norway and Poland. 1) A 1-year observational study to clarify the superiority of AI in adenoma detection in the average-risk population. 2) A cost-effectiveness analysis for cancer prevention, using real-world data obtained from the part 1 study. 3) Establishment of an infrastructure for long-term (10 years) follow-up of 40,000 individuals to quantify the effect of AI on colorectal cancer incidence.
We use propensity score matching to balance the background characteristics of the two comparing arms; AI-assisted colonoscopy and standard colonoscopy. Participants are followed through national cancer registries for ten years after cancer screening.
Our project is the first of its kind and made possible by the unique collaboration of world-class environments in clinical epidemiology and medical device assessment with world-leading AI developers. The project will enable evidence-based implementation of AI technologies into nationwide cancer screening programmes in Europe and the world.
The project’s achievement will be maximised through detailed plans for training, monitoring, management, exploitation, dissemination, and communication. While adding essential competence to the host institution, this project will increase the applicant’s skill, especially in epidemiologic aspects, helping him obtain an independent academic position in translational research of AI for medicine.